Kurt M Eichler - Net Worth and Insider Trading
Kurt M Eichler Net Worth
The estimated net worth of Kurt M Eichler is at least $5 Million dollars as of 2024-11-13. Kurt M Eichler is the Director of MiMedx Group Inc and owns about 574,576 shares of MiMedx Group Inc (MDXG) stock worth over $4 Million. Kurt M Eichler is the Director of Spring Bank Pharmaceuticals Inc and owns about 145,066 shares of Spring Bank Pharmaceuticals Inc (SBPH) stock worth over $702,119. Kurt M Eichler is also the Director of DARA Biosciences Inc and owns about 526,521 shares of DARA Biosciences Inc (DARA) stock worth over $463,338. Details can be seen in Kurt M Eichler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kurt M Eichler has not made any transactions after 2019-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kurt M Eichler
Kurt M Eichler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt M Eichler owns 4 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , MiMedx Group Inc (MDXG) , and DARA Biosciences Inc (DARA) among others .
Click here to see the complete history of Kurt M Eichler’s form 4 insider trades.
Insider Ownership Summary of Kurt M Eichler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-06-24 | director |
| MDXG | MiMedx Group Inc | 2010-12-31 | director |
| DARA | DARA Biosciences Inc | 2008-02-12 | director |
 | | 2016-05-05 | director |
Kurt M Eichler Latest Holdings Summary
Kurt M Eichler currently owns a total of 3 stocks. Among these stocks, Kurt M Eichler owns 574,576 shares of MiMedx Group Inc (MDXG) as of December 31, 2010, with a value of $4 Million and a weighting of 78.64%. Kurt M Eichler owns 145,066 shares of Spring Bank Pharmaceuticals Inc (SBPH) as of December 30, 2019, with a value of $702,119 and a weighting of 12.87%. Kurt M Eichler also owns 526,521 shares of DARA Biosciences Inc (DARA) as of February 12, 2008, with a value of $463,338 and a weighting of 8.49%.
Latest Holdings of Kurt M Eichler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDXG | MiMedx Group Inc | 2010-12-31 | 574,576 | 7.47 | 4,292,083 |
| SBPH | Spring Bank Pharmaceuticals Inc | 2019-12-30 | 145,066 | 4.84 | 702,119 |
| DARA | DARA Biosciences Inc | 2008-02-12 | 526,521 | 0.88 | 463,338 |
Holding Weightings of Kurt M Eichler
Kurt M Eichler Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 0 transactions in MiMedx Group Inc (MDXG) over the past 5 years. The most-recent trade in MiMedx Group Inc is the acquisition of 50,493 shares on December 31, 2010, which cost Kurt M Eichler around $49,988.
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 1 transactions in Spring Bank Pharmaceuticals Inc (SBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spring Bank Pharmaceuticals Inc is the sale of 10,000 shares on December 30, 2019, which brought Kurt M Eichler around $50,400.
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 0 transactions in DARA Biosciences Inc (DARA) over the past 5 years. The most-recent trade in DARA Biosciences Inc is the sale of 0 shares on February 12, 2008, which brought Kurt M Eichler around $0.
Insider Trading History of Kurt M Eichler
- 1
Kurt M Eichler Trading Performance
GuruFocus tracks the stock performance after each of Kurt M Eichler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt M Eichler is -12.53%. GuruFocus also compares Kurt M Eichler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt M Eichler within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kurt M Eichler's insider trading performs compared to the benchmark.
Performance of Kurt M Eichler
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.24 | | | | | |
| Relative Return to S&P 500(%) | -2.28 | | | | | |
Kurt M Eichler Ownership Network
Ownership Network List of Kurt M Eichler
Ownership Network Relation of Kurt M Eichler
Kurt M Eichler Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Kurt M Eichler is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Kurt M Eichler Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt M Eichler. You might contact Kurt M Eichler via mailing address: C/o Spring Bank Pharmaceuticals, Inc., Ste S-7, Milford Ma 01757.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
